| Rafael Evencio Molina, MD | |
|
1630 13th Ave, Huntington, WV 25701-3812 | |
| (304) 697-2014 | |
| Not Available |
| Full Name | Rafael Evencio Molina |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 1630 13th Ave, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003896796 | NPI | - | NPPES |
| 000000368678 | Other | OH | ANTHEM BC |
| 3810001850 | Medicaid | WV | |
| 001709561 | Other | OH | MT. STATE |
| 64107105 | Medicaid | KY | |
| 001709560 | Other | WV | MT. STATE |
| 2613578 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35086645 (Ohio) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 21985 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Health Systems, Inc | 9931017969 | 53 |
| Valley Health Systems, Inc | 9931017969 | 53 |
News Archive
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.
A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.
› Verified 7 days ago
| Entity Name | Valley Health Systems, Inc |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1902962368 PECOS PAC ID: 9931017969 Enrollment ID: O20040325000411 |
News Archive
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.
A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.
› Verified 7 days ago
| Entity Name | Valley Health Systems, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902962368 PECOS PAC ID: 9931017969 Enrollment ID: O20040325000570 |
News Archive
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.
A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.
› Verified 7 days ago
| Entity Name | Valley Health Systems, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720333461 PECOS PAC ID: 9931017969 Enrollment ID: O20130319000031 |
News Archive
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.
A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.
› Verified 7 days ago
| Entity Name | Valley Health Systems, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518680511 PECOS PAC ID: 9931017969 Enrollment ID: O20230303001765 |
News Archive
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.
A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rafael Evencio Molina, MD Po Box 1680, Huntington, WV 25717-1680 Ph: () - | Rafael Evencio Molina, MD 1630 13th Ave, Huntington, WV 25701-3812 Ph: (304) 697-2014 |
News Archive
Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.
A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is possible not only to accurately sort sick cardiac cell cultures from healthy ones, but also to differentiate between genetic cardiac diseases.
› Verified 7 days ago
Herbert Myers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Benjamin M Edwards, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701 Phone: 304-691-1400 Fax: 304-691-1453 | |
Richard Booth Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Dr. Jennie Lee Yoost, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr Ste 4500, Huntington, WV 25701 Phone: 304-691-1400 | |
William N Burns, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701 Phone: 304-691-1400 Fax: 304-691-1453 | |
Carolyn E. Clark, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1124 19th St, Huntington, WV 25701 Phone: 304-529-4117 Fax: 304-529-4110 |